市场调查报告书
商品编码
1298770
按材料(玻璃、玻璃陶瓷、复合材料和其他)、类型(粉末、可塑、颗粒和其他)、应用(牙科、外科、生物工程和其他)和地区分類的生物活性材料市场 2023-2028年Bioactive Materials Market by Material (Glass, Glass-ceramics, Composite, and Others), Type (Powder, Moldable, Granules, and Others), Application (Dentistry, Surgery, Bioengineering, and Others), and Region 2023-2028 |
全球生物活性材料市场规模在2022年达到25.1亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到56.1亿美元,在2023-2028年期间呈现13.10%的增长率(CAGR)。对再生医学的需求不断增长,具有增强特性的新的和改进的生物活性材料的开发,以及生物技术和生命科学领域的不断改进,代表了推动市场的一些关键因素。
生物活性材料是旨在与生物系统(如细胞、组织和器官)相互作用的成分。这些材料可以是合成的或天然的,主要用于各种医疗应用,包括组织工程、药物输送和再生医学。它们可以通过模仿目标组织的细胞外基质(ECM)促进特定的生物反应,如细胞粘附、增殖和分化。此外,它们还可以用于药物输送,在这种情况下,材料被设计为随着时间的推移释放药物或治疗剂。这对靶向给药很有用,药物直接释放到受影响的组织中,最大限度地减少副作用并提高疗效。因此,它们在全球范围内获得了广泛的重视,因为生物活性材料在医学领域有着广泛的应用,是推进各种疾病和状况治疗的重要工具。一些常见的生物活性材料包括羟基磷灰石和聚己内酯(PCL),它们被广泛用于骨移植和牙科植入物,并用于创建促进新组织生长的支架。
全球市场的主要驱动力是患者和医疗保健专业人士对再生医学的需求不断增长。再加上个人中慢性疾病的发病率越来越高,导致对创新治疗方案的需求越来越大,这为促进组织再生和修复的生物活性材料的需求提供了动力。与此同时,生物活性材料领域的持续技术进步,以及具有更强性能的新材料的开发,如生物相容性、生物可降解性和机械强度,正在创造一个积极的市场前景。此外,为开发新材料和应用而进行的广泛研究和开发(R&D)活动的投资不断增加,正成为一个增长的诱导因素。除此之外,私人和公共机构为升级整体医疗基础设施而不断增加的资金也对市场产生了有利的影响。同时,生物技术和生命科学领域的不断改进也大大支持了全球范围内对生物活性材料的需求。其他因素,包括快速的城市化、不断增长的老年人口以及在农村和地理范围内的医疗设施的发展,也在积极地影响着市场。
请注意,这只代表部分公司的名单,完整的名单已在报告中提供。
The global bioactive materials market size reached US$ 2.51 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.61 Billion by 2028, exhibiting a growth rate (CAGR) of 13.10% during 2023-2028. The growing demand for regenerative medicine, the development of new and improved bioactive materials with enhanced properties and continuous improvements in the field of biotechnology and life science represent some of the key factors driving the market.
Bioactive materials are constituents that are meant to interact with biological systems, such as cells, tissues, and organs. These materials can be synthetic or natural and are mainly used in a variety of medical applications, including tissue engineering, drug delivery, and regenerative medicine. They can promote specific biological responses, such as cell adhesion, proliferation, and differentiation, by mimicking the extracellular matrix (ECM) of the tissue being targeted. Additionally, they can also be utilized for drug delivery, where the material is designed to release a drug or therapeutic agent over time. This can be useful for targeted drug delivery, where the drug is released directly to the affected tissue, minimizing side effects and improving efficacy. As a result, they are gaining widespread prominence across the globe since bioactive materials have a wide range of applications in the medical field and are an important tool for advancing treatments for various diseases and conditions. Some of the common bioactive materials include hydroxyapatite and polycaprolactone (PCL) that are widely adopted for bone grafts and dental implants and to create scaffolds that promote the growth of new tissue.
The global market is majorly driven by the growing demand for regenerative medicine among patients and healthcare professionals. Coupled with the increasing prevalence of chronic diseases among individuals, leading to a growing need for innovative treatment options, this is providing a boost to the demand for bioactive materials to promote tissue regeneration and repair. Along with this, continual technological advancements in the field of bioactive materials and the development of new and improved materials with enhanced properties, such as biocompatibility, biodegradability, and mechanical strength, are creating a positive market outlook. Furthermore, the growing investments in extensive research and development (R&D) activities to develop new materials and applications are acting as a growth-inducing factor. Apart from this, the escalating funding by private and public agencies to upgrade the overall healthcare infrastructure is impacting the market favorably. Along with this, continuous improvements in the field of biotechnology and life science are significantly supporting the demand for bioactive materials across the globe. Other factors, including rapid urbanization, the growing geriatric population and the development of medical facilities across rural and geographically extended locations, are also positively influencing the market.
IMARC Group provides an analysis of the key trends in each segment of the global bioactive materials market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on material, type and application.
Glass
Glass-ceramics
Composite
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the material. This includes glass, glass-ceramics, composites and others. According to the report, glass represented the largest segment.
Powder
Moldable
Granules
Others
A detailed breakup and analysis of the bioactive materials market based on the type has also been provided in the report. This includes powder, moldable, granules and others. According to the report, powder type accounted for the largest market share.
Dentistry
Surgery
Bioengineering
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the application. This includes dentistry, surgery, bioengineering and others. According to the report, dentistry application exhibits a clear dominance in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioactive materials. Some of the factors driving the North America bioactive materials market included the growing investment in extensive research and development (R&D) activities, the emerging healthcare infrastructure, the development of medical facilities across rural and geographically extended locations, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global bioactive materials market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., BBS-Bioactive Bone Substitutes Oyj, Berkeley Advanced Biomaterials, Biomatlante SAS (Advanced Medical Solutions Group Plc), Ceraver, DePuy Synthes Inc. (Johnson & Johnson), Noraker, PULPDENT Corporation, Regenity Biosciences, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.